News

Scientists at the National Institutes of Health (NIH) have found that two common types of hormone therapy may alter breast cancer risk in women before age 55. Researchers discovered that women treated ...
The NIH's National Cancer Institute, which has long benefited from bipartisan support, now faces an exodus of clinicians and scientists.
Researchers in Europe and the U.S. have long collaborated to tackle tough scientific questions. Certain fields, like rare diseases, particularly benefit from international collaboration because it ...
Women who used at-home test kits were more than twice as likely to complete screening than those who received only telephone reminders.
Two tumor samples stained to highlight a molecular biomarker help differentiate between the two subtypes of pancreatic cancer. Red indicates the basal subtype; green indicates the classical subtype.
Watch a Melanoma Research Alliance presentation by Alexandra-Chloe Villani about immunotherapy side effects in this skin cancer.
The Food and Drug Administration (FDA) has loosened restrictions on CAR-T therapies for blood cancers, a move that is expected to make the revolutionary immunotherapy available to more people in more ...
Whole-genome sequencing study found air pollution to cause more cancer-related changes than secondhand smoke.
People diagnosed with localized prostate cancer are unlikely to die from the cancer if they are treated according to NCCN Guidelines.
Plan to slash Medicaid and Obamacare marketplace funding could lead to nearly 12 million more people without insurance by 2034.
Watch Princess Kate, visiting a hospital in England, open up about recovering from cancer and putting on a brave face during treatment.
On July 2, 2025, the Food and Drug Administration granted accelerated approval to sunvozertinib (Zegfrovy, Dizal (Jiangsu) Pharmaceutical Co., Ltd.) for adult patients with locally advanced or ...